# Announcements & Milestones

Partnerships, hires, financings, and platform releases from the Verge Labs team.

## 2026

- [Press · Platform · June 17, 2026  
  **STAT News: “Verge Labs’ new AI model solves patient stratification problems for neurology clinical trials”**](https://www.statnews.com/2026/06/16/verge-labs-ai-model-clinical-trials-data-neurology-diseases/)
- [Platform · CNS · Clinical · June 16, 2026  
  **Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology**  
  By Verge Labs](https://vergelabs.com/resources/news/vbx-launch/)
- [Partnerships · Pipeline · CNS · June 9, 2026  
  **Verge Labs and Tenacia Biotechnology Partner to Advance Tenacia’s CNS Pipeline Using Human Data**  
  By Verge Labs](https://vergelabs.com/resources/news/tenacia-cns-partnership/)

## 2025

- [Clinical · ALS · Biomarkers · April 7, 2025  
  **Digital biomarkers detect short-term ALS progression in VRG50635 trial run-in**  
  By Verge Genomics](https://vergelabs.com/resources/news/digital-biomarkers-vrg50635/)

## 2024

- [Partnerships · Pipeline · ALS · November 20, 2024  
  **Lilly selects two ALS targets from CONVERGE® collaboration**  
  By Verge Genomics](https://vergelabs.com/resources/news/lilly-milestones-2024/)

## 2023

- [Clinical · ALS · Pipeline · November 29, 2023  
  **VRG50635 proof-of-concept study initiated in patients with ALS**  
  By Verge Genomics](https://vergelabs.com/resources/news/vrg50635-poc-initiation/)
- [Partnerships · Neuropsychiatry · October 31, 2023  
  **Verge Genomics and the Pritzker Consortium form schizophrenia research collaboration**  
  By Verge Genomics](https://vergelabs.com/resources/news/pritzker-schizophrenia/)
- [Partnerships · Pipeline · Rare Disease · September 8, 2023  
  **Verge Genomics and Alexion launch AI-enabled drug discovery collaboration for rare neuro diseases**  
  By Verge Genomics](https://vergelabs.com/resources/news/alexion-collaboration/)
- [Clinical · ALS · Pipeline · June 15, 2023  
  **Positive Phase 1 safety and tolerability data for VRG50635**  
  By Verge Genomics](https://vergelabs.com/resources/news/vrg50635-phase1-safety/)

## 2022

- [Leadership · Recognition · November 14, 2022  
  **Alice Zhang named to Fortune 40 Under 40 and Fierce Biotech’s Fiercest Women in Life Sciences**  
  By Verge Genomics](https://vergelabs.com/resources/news/alice-zhang-fortune-fierce/)
- [Clinical · ALS · Pipeline · October 31, 2022  
  **First-in-human dosing of VRG50635 begins in Phase 1 trial**  
  By Verge Genomics](https://vergelabs.com/resources/news/vrg50635-first-in-human/)
- [Leadership · Recognition · October 12, 2022  
  **Alice Zhang honored by Goldman Sachs as one of 2022’s Most Exceptional Entrepreneurs**  
  By Verge Genomics](https://vergelabs.com/resources/news/goldman-sachs-honor/)
- [Recognition · Company · September 12, 2022  
  **Fierce Biotech names Verge Genomics a 2022 “Fierce 15” biotech company**  
  By Verge Genomics](https://vergelabs.com/resources/news/fierce-15-2022/)

## 2021

- [Partnerships · Pipeline · ALS · July 8, 2021  
  **Verge Genomics and Eli Lilly announce three-year ALS collaboration**  
  By Verge Genomics](https://vergelabs.com/resources/news/lilly-collaboration-2021/)

## 2020

- [Platform · Publication · October 5, 2020  
  **New approach for uncovering novel drug targets from human genetics published in PLOS Computational Biology**  
  By Verge Genomics](https://vergelabs.com/resources/news/bagea-publication/)